Employer Active
Job Alert
You will be updated with latest job alerts via emailJob Alert
You will be updated with latest job alerts via emailNot Disclosed
Salary Not Disclosed
1 Vacancy
Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery development and commercialization of targeted protein degradation medicines the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases. Powered by a fully AIintegrated discovery engine capable of tackling any protein class and coupled with unparalleled ligase expertise Nurixs dedicated team has built a formidable advantage in translating the science of targeted protein degradation into clinical advancements. Nurix aims to establish degraderbased treatments at the forefront of patient care writing medicines next chapter with a new script to outmatch disease.
Nurix Inc. is seeking a Clinical Trial Manager (CTM)/Sr. CTM to join the Clinical Operations team. This individual will be responsible for management of assigned clinical trials and/or global regions. They will lead study team vendors clinical monitors and clinical sites throughout the life cycle of a clinical trial.
This individual will be able to manage clinical regions and/or trial(s) and have broad involvement in work central to Nurixs strategic goals. They will apply existing technical skills learn new skills and play a key role in clinical development of the programs.
The CTM/Sr. CTM is responsible for the successful implementation of assigned clinical trial(s) independently from startup to closeout. Experience in managing crossfunctional teams vendor oversight knowledge of applicable regulatory requirements and developing junior staff will be essential to the teams success. The CTM/Sr. CTM will represent Clinical Operations at Project team meetings and may represent Nurix at professional events.
Job Responsibilities:
Experience and Skills
Company
Nurix Therapeutics is a biopharmaceutical company focused on the discovery development and commercialization of small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. Leveraging Nurixs extensive expertise in E3 ligases together with its proprietary DNAencoded libraries Nurix has built DELigase an integrated discovery platform to identify and advance novel drug candidates targeting E3 ligases a broad class of enzymes that can modulate proteins within the cell. Nurixs drug discovery approach is to either harness or inhibit the natural function of E3 ligases within the ubiquitin proteasome system to selectively decrease or increase cellular protein levels.
Nurixs wholly owned pipeline comprises targeted protein degraders of Brutons tyrosine kinase a Bcell signaling protein and inhibitors of Casitas Blineage lymphoma protooncogeneB an E3 ligase that regulates T cell activation. Nurix is headquartered in San Francisco California.
Nurix Therapeutics Inc. is committed to protecting and respecting your privacy and personal information including information collected by Nurix when you apply for a job with Nurix or in the course of your employment with Nurix. By applying for a position at Nurix you agree to our collection and use of personal information as described in our Privacy Policy Experience:
Manager
Full Time